Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. [electronic resource] by
- Glintborg, B
- Kringelbach, T
- Bolstad, N
- Warren, D J
- Eng, G
- Sørensen, I J
- Loft, A G
- Hendricks, O
- Hansen, Imj
- Linauskas, A
- Nordin, H
- Kristensen, S
- Lindegaard, H
- Jensen, D V
- Goll, G L
- Høgdall, E
- Gehin, J
- Enevold, C
- Nielsen, C H
- Krogh, N S
- Johansen, J S
- Hetland, M L
Producer: 20180924
In:
Scandinavian journal of rheumatology vol. 47
Availability: No items available.
|
|
|
120.
|
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial. [electronic resource] by
- Goll, G L
- Jørgensen, K K
- Sexton, J
- Olsen, I C
- Bolstad, N
- Haavardsholm, E A
- Lundin, K E A
- Tveit, K S
- Lorentzen, M
- Berset, I P
- Fevang, B T S
- Kalstad, S
- Ryggen, K
- Warren, D J
- Klaasen, R A
- Asak, Ø
- Baigh, S
- Blomgren, I M
- Brenna, Ø
- Bruun, T J
- Dvergsnes, K
- Frigstad, S O
- Hansen, I M
- Hatten, I S H
- Huppertz-Hauss, G
- Henriksen, M
- Hoie, S S
- Krogh, J
- Midtgard, I P
- Mielnik, P
- Moum, B
- Noraberg, G
- Poyan, A
- Prestegård, U
- Rashid, H U
- Strand, E K
- Skjetne, K
- Seeberg, K A
- Torp, R
- Ystrøm, C M
- Vold, C
- Zettel, C C
- Waksvik, K
- Gulbrandsen, B
- Hagfors, J
- Mørk, C
- Jahnsen, J
- Kvien, T K
Producer: 20200507
In:
Journal of internal medicine vol. 285
Availability: No items available.
|